PFG Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,132
Closed -$230K 739
2024
Q3
$230K Buy
2,132
+23
+1% +$2.51K 0.01% 654
2024
Q2
$229K Buy
2,109
+105
+5% +$12.4K 0.02% 622
2024
Q1
$265K Buy
2,004
+105
+6% +$13.1K 0.02% 552
2023
Q4
$231K Buy
1,899
+84
+5% +$9.37K 0.02% 557
2023
Q3
$204K Buy
1,815
+126
+7% +$16K 0.02% 574
2023
Q2
$246K Buy
+1,689
New +$230K 0.02% 579
2023
Q1
Sell
-1,686
Closed -$215K 656
2022
Q4
$215K Buy
+1,686
New +$196K 0.02% 522

Other funds holding ZBH

PFG Advisors's ZBH Position: Q4 2024 in Review

PFG Advisors sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 2,132 shares — an estimated $230K sold.

PFG Advisors first reported a position in ZBH in Q4 2022 and held it in 7 quarters. The position peaked at $265K in Q1 2024. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • PFG Advisors reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • PFG Advisors sold 2,132 Zimmer Biomet shares in Q4 2024, an estimated $230K.
  • PFG Advisors first reported a position in Zimmer Biomet in Q4 2022 and held it in 7 quarters.
  • PFG Advisors's Zimmer Biomet position peaked at $265K in Q1 2024.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on PFG Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.